1 month DAWN Q3 EPS Estimate Boosted by Capital One FinancialMarketBeat
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) – Analysts at Capital One Financial upped their Q3 2024 EPS estimates for Day One Biopharmaceuticals in a research note issued on Wednesday, October 16th. Capital One Financial analyst N. …
Capital One Financial (COF) · Nasdaq 100 · Science
X